{"url_path":"/sec/cnmd/8-k/2026-06-01/item-9-01","section_key":"item-9-01","section_title":"Item 9.01 **","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-06-01","source_url":"https://www.sec.gov/Archives/edgar/data/816956/0002077096-26-000190-index.html","accession_number":"0002077096-26-000190","cik":"0000816956","ticker":"CNMD","issuer_name":"CONMED Corp","edgar_url":"https://www.sec.gov/Archives/edgar/data/816956/0002077096-26-000190-index.html","primary_entity_key":"0000816956","primary_entity_name":"CONMED Corp"},"word_count":142,"has_tables":true,"body_markdown":"**Item 9.01**\n**Financial Statements and Exhibits.**\n\n** **\n\n**(d) Exhibits**\n\n \n\nThe following exhibits are included herewith:\n\n \n\n**Exhibit\nNumber**\n \n**Description**\n\n10.1\n \n[First Omnibus Amendment and Increased Facility Activation Notice, dated as of May 27, 2026, among CONMED Corporation, Linvatec Nederland B.V., a Netherlands private limited company (*besloten vennootschap*), certain other subsidiaries of CONMED Corporation party thereto, the several banks and other financial institutions party thereto party thereto, and JPMorgan Chase Bank, N.A., as administrative agent.](ea029246401ex10-1.htm)\n\n104\n \nCover Page Interactive Data File (embedded within the Inline XBRL document).\n\n \n\n 2\n\n \n\n**SIGNATURES**\n\n \n\nPursuant to the requirements of the Securities Exchange Act of 1934,\nthe Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.\n\n \n\n \n**CONMED CORPORATION**\n\n \n(Registrant)\n\n \n \n\n \nBy:\n/s/ Patrick Beyer\n\n \n \nName: \nPatrick Beyer\n\n \n \nTitle:\nPresident and Chief Executive Officer and\n\n \n \nInterim Principal Financial\nOfficer\n\n \n \n\nDate: June 1, 2026\n \n\n \n\n 3"}